Clinical Trials Directory

Trials / Conditions / House Dust Mite Allergy

House Dust Mite Allergy

23 registered clinical trials studyying House Dust Mite Allergy1 currently recruiting.

StatusTrialSponsorPhase
CompletedEvaluation of an Adjusted Cutoff Value for S.P.A.T (Skin Prick Automated Test) Device in Allergic Subjects
NCT06803953
HippocreatesN/A
Active Not RecruitingA Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mi
NCT06920771
HAL AllergyPhase 3
UnknownEfficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/Rhinoconjunctivit
NCT05400811
Inmunotek S.L.Phase 3
UnknownThe Efficacy of Nigella Sativa in Children With House Dust Mite-Induced Respiratory Allergy Receiving Immunoth
NCT05450289
Universitas AirlanggaN/A
RecruitingEfficacy and Safety Assessment of Beltavac® With Polymerized Extract of HDM
NCT05395689
Probelte Pharma S.L.U.Phase 3
CompletedSkin Responses and T Cell Immunology After House Dust Mite Exposure in Sensitized Atopic Dermatitis Patients
NCT05019209
Fraunhofer-Institute of Toxicology and Experimental MedicineN/A
UnknownEpigenetic Regulation of Exercise Induced Asthma
NCT05174689
Johann Wolfgang Goethe University HospitalN/A
TerminatedEfficacy and Safety Evaluation for the Treatment of Asthma and Allergic Rhinitis/Rhinoconjunctivitis
NCT04874714
Inmunotek S.L.Phase 3
CompletedDiagnostic Accuracy of the MADx Multi Array Xplorer (MAX 45k) Automated Laboratory System and the MADx Allergy
NCT04435678
MacroArray Diagnostics GmbHN/A
CompletedSafety and Clinical Tolerability of hdmASIT+TM Peptides Administered in HDM-induced Allergic Patients
NCT03094845
ASIT Biotech S.A.Phase 2
CompletedEfficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-ass
NCT02443805
Stallergenes GreerPhase 3
CompletedSUBLIVAC FIX Mite Mixture Dose Tolerability Study
NCT02345278
HAL AllergyPhase 1 / Phase 2
UnknownAZELASTINE/FLUTICASONE (AZE/FLU) Nasal Spray on Symptom Control, Nasal Mediators and Nasal Hyperresponsiveness
NCT02238353
Universitaire Ziekenhuizen KU LeuvenPhase 4
CompletedToleroMune House Dust Mite Follow on Study
NCT01923792
Circassia Limited
CompletedDose Ranging Study of SLIT Tablets of House Dust Mite Allergen Extracts (HDM) in Adults With HDM-associated Al
NCT01930461
Stallergenes GreerPhase 2
TerminatedRole of the Central Nervous System in Allergic Rhinitis
NCT01777464
Universitaire Ziekenhuizen KU LeuvenN/A
CompletedSafety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts
NCT01608243
Stallergenes GreerPhase 1
CompletedA One Year Trial Evaluating the Safety and Efficacy of the ALK House Dust Mite Allergy Tablet
NCT01454544
ALK-Abelló A/SPhase 3
CompletedSafety of Bronchial Allergen Challenge and Predictors for Positive Reaction.
NCT01134757
Johann Wolfgang Goethe University HospitalN/A
CompletedA Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivit
NCT00574223
Cytos Biotechnology AGPhase 2
CompletedA Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivit
NCT00574704
Cytos Biotechnology AGPhase 2
CompletedFish Oil and Asthma in House Dust Mite Allergy
NCT00380926
Johann Wolfgang Goethe University HospitalPhase 2 / Phase 3
CompletedSafety and Efficacy of House Dust Mite Allergen Extract in the Treatment of Allergic Rhinoconjunctivitis
NCT00263549
Allergopharma GmbH & Co. KGPhase 4